Cargando…

CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells

BACKGROUND: Chronic myeloid leukemia is a clonal myeloproliferative disorder disease in which BCR/ABL plays an important role as an oncoprotein and molecular target. Despite the success of targeted therapy using tyrosine kinase inhibitors, CML remains largely incurable, most likely due to the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Guoqiang, Zhang, Hongju, Wang, Jian, Zhang, Yujuan, Xu, Hua, Wang, Chijuan, Zhang, Hairui, Ma, Li, Li, Qinghua, Pang, Tianxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176735/
https://www.ncbi.nlm.nih.gov/pubmed/24257075
http://dx.doi.org/10.1186/1475-2867-13-117
_version_ 1782336671642025984
author Chang, Guoqiang
Zhang, Hongju
Wang, Jian
Zhang, Yujuan
Xu, Hua
Wang, Chijuan
Zhang, Hairui
Ma, Li
Li, Qinghua
Pang, Tianxiang
author_facet Chang, Guoqiang
Zhang, Hongju
Wang, Jian
Zhang, Yujuan
Xu, Hua
Wang, Chijuan
Zhang, Hairui
Ma, Li
Li, Qinghua
Pang, Tianxiang
author_sort Chang, Guoqiang
collection PubMed
description BACKGROUND: Chronic myeloid leukemia is a clonal myeloproliferative disorder disease in which BCR/ABL plays an important role as an oncoprotein and molecular target. Despite the success of targeted therapy using tyrosine kinase inhibitors, CML remains largely incurable, most likely due to the treatment resistance after firstly chemical therapy. So know well the unique molecular pathway of CML is very important. METHODS: The expressions of CD44 in different leukemia patients and cell lines were detected by real-time PCR and western blotting. The effects of CD44 on proliferation of K562 cells were determined using the MTT and colony formation assays, and even in a nude mouse transplantation model. Then, the cell cycle changes were detected by flow cytometric analysis and the early apoptosis of cells was detected by the annexin V/propidium iodide double-staining assay. The expressions of the cycles and apoptosis-related proteins p21, Cyclin D1 and Bcl-2 were analyzed by western blot and real-time PCR assay. Finally, the decreased nuclear accumulation of β-catenin was detected by western blotting and immunefluorescence. RESULTS: Firstly, we showed that CD44 expression was increased in several kinds of leukemia patients and K562 cells. By contrast, the down-regulation of CD44 resulted in decreased proliferation with a G(0)/G(1) arrest of cell cycle in K562 cells according to the MTT assay and the flow cytometric analysis. And no significant induction of both the early and late phases of apoptosis was shown by the annexin V-FITC and PI staining. During this process, p21 and cyclin D1 are the major causes for cell cycle arrest. In addition, we found CD44 down-regulation decreased the expression of β-catenin and increased the expression of phosphorylated β-catenin. The instability of Wnt/β-catenin pathway induced by increased expression of p-β-catenin resulted in a decreased nuclear accumulation in CD44 silenced K562 cells. In the nude mouse transplantation model, we also found the same results. CONCLUSIONS: These results show that K562 cells depend to a greater extent on CD44 for proliferation, and CD44 down-regulation may induce a cell cycle arrest through Wnt/β-catenin pathway. CD44 blockade may be beneficial in therapy of CML.
format Online
Article
Text
id pubmed-4176735
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41767352014-09-28 CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells Chang, Guoqiang Zhang, Hongju Wang, Jian Zhang, Yujuan Xu, Hua Wang, Chijuan Zhang, Hairui Ma, Li Li, Qinghua Pang, Tianxiang Cancer Cell Int Primary Research BACKGROUND: Chronic myeloid leukemia is a clonal myeloproliferative disorder disease in which BCR/ABL plays an important role as an oncoprotein and molecular target. Despite the success of targeted therapy using tyrosine kinase inhibitors, CML remains largely incurable, most likely due to the treatment resistance after firstly chemical therapy. So know well the unique molecular pathway of CML is very important. METHODS: The expressions of CD44 in different leukemia patients and cell lines were detected by real-time PCR and western blotting. The effects of CD44 on proliferation of K562 cells were determined using the MTT and colony formation assays, and even in a nude mouse transplantation model. Then, the cell cycle changes were detected by flow cytometric analysis and the early apoptosis of cells was detected by the annexin V/propidium iodide double-staining assay. The expressions of the cycles and apoptosis-related proteins p21, Cyclin D1 and Bcl-2 were analyzed by western blot and real-time PCR assay. Finally, the decreased nuclear accumulation of β-catenin was detected by western blotting and immunefluorescence. RESULTS: Firstly, we showed that CD44 expression was increased in several kinds of leukemia patients and K562 cells. By contrast, the down-regulation of CD44 resulted in decreased proliferation with a G(0)/G(1) arrest of cell cycle in K562 cells according to the MTT assay and the flow cytometric analysis. And no significant induction of both the early and late phases of apoptosis was shown by the annexin V-FITC and PI staining. During this process, p21 and cyclin D1 are the major causes for cell cycle arrest. In addition, we found CD44 down-regulation decreased the expression of β-catenin and increased the expression of phosphorylated β-catenin. The instability of Wnt/β-catenin pathway induced by increased expression of p-β-catenin resulted in a decreased nuclear accumulation in CD44 silenced K562 cells. In the nude mouse transplantation model, we also found the same results. CONCLUSIONS: These results show that K562 cells depend to a greater extent on CD44 for proliferation, and CD44 down-regulation may induce a cell cycle arrest through Wnt/β-catenin pathway. CD44 blockade may be beneficial in therapy of CML. BioMed Central 2013-11-20 /pmc/articles/PMC4176735/ /pubmed/24257075 http://dx.doi.org/10.1186/1475-2867-13-117 Text en Copyright © 2013 Chang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Primary Research
Chang, Guoqiang
Zhang, Hongju
Wang, Jian
Zhang, Yujuan
Xu, Hua
Wang, Chijuan
Zhang, Hairui
Ma, Li
Li, Qinghua
Pang, Tianxiang
CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
title CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
title_full CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
title_fullStr CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
title_full_unstemmed CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
title_short CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells
title_sort cd44 targets wnt/β-catenin pathway to mediate the proliferation of k562 cells
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176735/
https://www.ncbi.nlm.nih.gov/pubmed/24257075
http://dx.doi.org/10.1186/1475-2867-13-117
work_keys_str_mv AT changguoqiang cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT zhanghongju cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT wangjian cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT zhangyujuan cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT xuhua cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT wangchijuan cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT zhanghairui cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT mali cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT liqinghua cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells
AT pangtianxiang cd44targetswntbcateninpathwaytomediatetheproliferationofk562cells